Daniel Scott Auld

Title: Daniel Scott Auld: Innovator in Pancreatic Cancer Therapy

Introduction

Daniel Scott Auld is a notable inventor based in Pointe-Claire, Canada. He has made significant contributions to the field of medical research, particularly in the area of pancreatic cancer therapy and diagnosis. His innovative approach aims to improve treatment outcomes for patients suffering from this challenging disease.

Latest Patents

Daniel Scott Auld holds a patent for a novel method of treating pancreatic cancer and pancreatitis. This method involves a combination of a dopamine receptor antagonist, such as pimozide, haloperidol, and/or L-741,626, along with 2-deoxy-D-glucose and atorvastatin. The treatment may also be used in conjunction with gemcitabine, providing a multifaceted approach to combatting pancreatic cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Auld has worked with prestigious institutions, including McGill University and the German Cancer Research Center (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). His work has been instrumental in advancing research in cancer therapies, showcasing his dedication to improving patient care.

Collaborations

Daniel Scott Auld has collaborated with esteemed colleagues, including Yasser Riaz Alhosseini and Veena Sangwan. These partnerships have contributed to the development of innovative solutions in cancer treatment.

Conclusion

Daniel Scott Auld's contributions to pancreatic cancer therapy highlight his commitment to medical innovation. His work continues to inspire advancements in the field, ultimately aiming to enhance the lives of those affected by this disease.